CAPTRUST Financial Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26K | Buy |
+11,802
| New | +$26K | ﹤0.01% | 2462 |
|
|
2022
Q3 | – | Sell |
-1,643
| Closed | -$19K | – | 2615 |
|
|
2022
Q2 | $19K | Sell |
1,643
-691
| -30% | -$7.99K | ﹤0.01% | 3400 |
|
|
2022
Q1 | $44K | Sell |
2,334
-5,943
| -72% | -$112K | ﹤0.01% | 2875 |
|
|
2021
Q4 | $220K | Sell |
8,277
-19,439
| -70% | -$517K | ﹤0.01% | 1573 |
|
|
2021
Q3 | $1.14M | Buy |
27,716
+3,757
| +16% | +$154K | 0.01% | 706 |
|
|
2021
Q2 | $1.36M | Buy |
23,959
+659
| +3% | +$37.3K | 0.01% | 615 |
|
|
2021
Q1 | $979K | Buy |
23,300
+172
| +0.7% | +$7.23K | 0.01% | 703 |
|
|
2020
Q4 | $1.62M | Buy |
23,128
+6,808
| +42% | +$477K | 0.02% | 458 |
|
|
2020
Q3 | $460K | Buy |
16,320
+9,160
| +128% | +$258K | 0.01% | 742 |
|
|
2020
Q2 | $221K | Sell |
7,160
-2,720
| -28% | -$84K | ﹤0.01% | 989 |
|
|
2020
Q1 | $183K | Buy |
9,880
+1,855
| +23% | +$34.4K | ﹤0.01% | 891 |
|
|
2019
Q4 | $236K | Buy |
8,025
+7,925
| +7,925% | +$233K | ﹤0.01% | 925 |
|
|
2019
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 1792 |
|
|
2019
Q2 | $2K | Sell |
100
-1,679
| -94% | -$33.6K | ﹤0.01% | 1798 |
|
|
2019
Q1 | $43K | Buy |
1,779
+1,679
| +1,679% | +$40.6K | ﹤0.01% | 953 |
|
|
2018
Q4 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1479 |
|